Paraneoplastic syndrome or immune-related adverse event? A case of rhomboencephalitis in a patient treated with Pembrolizumab

Acta Neurol Belg. 2021 Oct;121(5):1341-1342. doi: 10.1007/s13760-020-01564-3. Epub 2021 Jan 3.

Authors

G Abbadessa¹, G Miele², M Fratta², S Bonavita²

Affiliations

¹ Department of Advanced Medical and Surgical Sciences, Second Division of Neurology, University of Campania Luigi Vanvitelli, Via Pansini 5, 80131, Napoli, Italy. gianmarcoabbadessa@live.com.
² Department of Advanced Medical and Surgical Sciences, Second Division of Neurology, University of Campania Luigi Vanvitelli, Via Pansini 5, 80131, Napoli, Italy.

PMID: 33393070
DOI: 10.1007/s13760-020-01564-3

No abstract available

Keywords: Case report; Immunotherapy; Neuroimmunology; Paraneoplastic neurological syndrome.

Publication types

Case Reports
Letter

MeSH terms

Adenocarcinoma of Lung / drug therapy*
Antibodies, Monoclonal, Humanized / adverse effects*
Diagnosis, Differential
Encephalitis / chemically induced
Encephalitis / diagnosis*
Female
Humans
Lung Neoplasms / drug therapy*
Middle Aged
Paraneoplastic Syndromes / diagnosis*

Substances

Antibodies, Monoclonal, Humanized
pembrolizumab